Sai Life Sciences Limited
SAILIFE · ISIN: INE570L01029
Sai Life Sciences Limited is a small cap company in the Pharmaceuticals & Biotechnology sector, listed on the NSE under ISIN INE570L01029.
Price and day-range figures above come from the latest NSE/BSE close, not a delayed quote. Where shown, RSI (14-day), SMA50/SMA200, and ADX measure momentum and trend from real daily closing prices - an RSI above 70 or below 30 typically signals overbought or oversold conditions, and a price above its SMA200 is a common long-term uptrend marker. ADTV (20-day average daily traded value) reflects real liquidity, not a projection. Fundamentals, when available, come from the company's own filed financials rather than a third-party estimate.
Constituent of NIFTY 500 TRI (0.11%), NIFTY SC 250 TRI (0.96%)
CHART
Sai Life Sciences Limited - growth of ₹100
Growth of ₹100 invested on 2026-05-08, not raw price - the standard way to compare performance regardless of price level. Daily resolution for the last 90 days, weekly up to 2 years, monthly beyond that.
1M
-1.89%
3M
+13.73%
6M
+39.86%
1Y
+67.11%
3Y CAGR
-
5Y CAGR
-
Earnings (TTM)
LEARN: Revenue and PAT · EPS · P/E
CHART
Sai Life Sciences Limited - revenue & profit (TTM)
Trailing-twelve-month figures by reported quarter, in ₹ Cr. Latest quarter: 2026-06-30.
Technicals
As of 2026-10-29.
Shareholding Pattern
CHART
Shareholding by category
As of 2026-06-30.
Corporate Actions
No corporate actions on record for this stock.
Recent Deals
No recent block/bulk/short-sell deals on record for this stock.
Frequently asked questions
What is Sai Life Sciences Limited's 1-year and 3-year return?
Sai Life Sciences Limited's 1-year price return is +67.11%. Both are price-only returns (no dividends added back), computed from the nearest available trading day to each anniversary - not a forecast of future performance.
What is Sai Life Sciences Limited's latest financial performance?
Sai Life Sciences Limited's trailing-twelve-month (TTM) revenue as of 2026-06-30 is ₹2,250 Cr, with a TTM profit after tax of ₹362 Cr and an EBITDA margin of 23.02%. TTM figures sum the most recent four reported quarters rather than a single quarter, which smooths out seasonal swings in a business's revenue and profit. EPS (earnings per share) over this TTM window is ₹17.17.
What is Sai Life Sciences Limited's quality score?
Sai Life Sciences Limited has a Punji quality score of 66.7 out of 100 as of 2026-06-30. This composite score is computed from the company's reported fundamentals (profitability, balance-sheet strength, and consistency of earnings, among other factors) and is designed to be comparable across companies in different sectors. A higher score indicates a fundamentally stronger business by these measures, though it isn't a price target or a buy/sell signal - a high-quality company can still be expensively priced, and a lower-scoring one can still be a reasonable investment at the right valuation.
What do Sai Life Sciences Limited's technical indicators show?
As of 2026-10-29, Sai Life Sciences Limited's RSI (14-day) is 53.8 - readings above 70 typically signal an overbought stock, below 30 an oversold one, so this reading sits in neutral territory. Its 50-day moving average is currently above its 200-day moving average, a "golden cross" setup when the shorter average is above (often read as a bullish medium-term signal) or a "death cross" when below (often read as bearish). These are backward-looking statistical measures, not predictions of future price movement.
Who are the major shareholders of Sai Life Sciences Limited?
As of 2026-06-30, Sai Life Sciences Limited's shareholding is split across Promoter (34.5%), Public (65.5%), NonPromoterNonPublic (null%). Promoter holding of 34.5% indicates the founders/controlling group's own stake in the company - a higher promoter holding is often read as a sign of management's confidence in the business, though it should be considered alongside pledge status and recent buying/selling activity, which this figure alone doesn't capture.
Is Sai Life Sciences Limited part of any major market index?
Yes - Sai Life Sciences Limited is a constituent of NIFTY 500 TRI (0.11% weight) and NIFTY SC 250 TRI (0.96% weight). Index membership means the stock is automatically bought by every index fund and ETF tracking that benchmark, in proportion to its weight, which brings a baseline level of passive-fund demand independent of active investor sentiment. A stock's weight in an index is typically determined by its free-float market capitalization relative to the index's other constituents, and is periodically rebalanced as relative market caps shift.
Stock data · Not financial advice · Past performance does not indicate future returns